Roth Capital Upgrades Core Scientific to 'Buy'—Cites Increased Likelihood of CoreWeave M&A Collapse

Roth Capital Partners upgrades Core Scientific to 'Buy' and raises its price target, citing increased standalone value as the likelihood of a CoreWeave acquisition fades.